story of the week
Association Between Use of Systemic Corticosteroids and Mortality in Critically Ill Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- Effect of Dexamethasone on Days Alive and Ventilator–Free in Patients With Moderate or Severe ARDS and COVID-19
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-Analysis
JAMA 2020 Sep 02;[EPub Ahead of Print], JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, LCP Azevedo, O Berwanger, AB Cavalcanti, PF Dequin, B Du, J Emberson, D Fisher, B Giraudeau, AC Gordon, A Granholm, C Green, R Haynes, N Heming, JPT Higgins, P Horby, P Jüni, MJ Landray, A Le Gouge, M Leclerc, WS Lim, FR Machado, C McArthur, F Meziani, MH Møller, A Perner, MW Petersen, J Savovic, B Tomazini, VC Veiga, S Webb, JC MarshallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.